In addition to benefitting Americans by lowering the cost to develop new pharmaceuticals, the move will also help make the US more competitive with China.

The post FDA Moves to Curb Monkey Testing for Monoclonal Antibody Products first appeared on Le·gal In·sur·rec·tion.